Pharmafile Logo

EY Life Sciences

Our global reach
Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and adaptability critical for success. Our worldwide team of 190,000 industry-focused management consulting, compliance, business development and tax professionals — with deep sector knowledge and technical experience — can help you address these myriad changes and compete effectively in this dynamic environment. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

Strength and depth in the Life Sciences sector
EY is known for its deep power and Life Sciences sector knowledge, relationships with the industry’s key stakeholders, and strong global capabilities. Clients see us as the most globally connected organization among the Big Four. Whether you are already active in multiple geographies or are planning to expand your business to other countries, we can assemble a multinational team that combines deep industry knowledge, experience resolving the issues you are facing, and savvy local advice.

Our Global Life Sciences Team is committed to delivering industry insight that creates value for you. It connects our Life Sciences professionals worldwide and serves as a hub for sharing industry-focused knowledge to help you succeed in a changing world. We make it our business to understand your business and to keep our advice relevant to your needs. We work with you as you transform your business, helping you anticipate the pitfalls and lock in the results on which your future depends. EY serves all of the Forbes Global 2000 top 10 life sciences companies and audits 26% of the global life sciences companies on the list. In addition, EY audits 30% of revenues of the global life sciences companies on the Forbes Global 2000 list.

This broad and deep exposure means we understand the dynamics of the sector and the underlying drivers of the leading actors and our Global Life Sciences sector team, is dedicated to offering industry insight and coordinating a network of more than 7,500 Life Sciences professionals worldwide who are ready to develop practical approaches to solving your problems.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

Ernst & Young LLP, 1 More London Place, London, SE1 2AF, United Kingdom

 Latest Content from PMHub 

Supporting the people who support patients

Press Releases | August 28, 2026 | Mednet

Supporting those who provide care can lead to improved experiences and health outcomes for everyone involved.

NEW PHARMA-EXCLUSIVE WEBINAR: Beyond the Hype; Practical, Compliant AI Solutions for Pharma Engagement

Press Releases | August 27, 2026 | Impetus Digital

See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards

Intelligent Commercialization™ across the pharma lifecycle

Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.

Four steps to a smarter congress strategy: A practical guidebook

This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.

Real Chemistry Deepens German Market Expertise with Appointment of Dirk Poschenrieder as Managing Director, Germany

Press Releases | August 25, 2026 | Real Chemistry

Senior hire strengthens Real Chemistry’s ability to help healthcare clients connect global strategy to nuanced needs for in-market execution

Cutting the friction from health comms through whole-person design

Press Releases | August 24, 2026 | Mednet

Good design can’t change the reality of illness, remove the pain, or stop the uncertainty. But it can stop learning what comes next from being another burden to carry.

The Future of Decisioning

Press Releases | August 20, 2026 | Havas Lynx

The traditional model for gathering insights is reaching a breaking point. Healthcare Professionals (HCPs) are increasingly time-poor and difficult to reach. Simultaneously, the costs of traditional market research are rising,...

Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth

Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board

Treating phase 2 study design as a scientific decision is compromising launch performance, warns expert

Press Releases | August 17, 2026 | Nmblr

17th August 2026 – Treating Phase 2 study design solely as a set of scientific decisions, without commercial input, is compromising launch performance, according to Janice MacLennan, founder of Nmblr,...

Genesis Research Group Appoints Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR

Genesis Research Group today announced the appointment of Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR. She joins the Executive Leadership Team and will lead the company’s global real-world evidence...